You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/140573
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBersano, Paulo Ricardo de Oliveira-
dc.contributor.authorAlves, Maria Teresa de Seixas-
dc.contributor.authorGärtner, Maria de Fátima Rodrigues Moutinho-
dc.contributor.authorFerrasi, Adriana Camargo-
dc.contributor.authorLima Neto, João Ferreira de-
dc.contributor.authorLandim, Fernanda da Cruz-
dc.contributor.authorVexenat, Stephane Cássia-
dc.contributor.authorAlves, Carlos Eduardo Fonseca-
dc.contributor.authorSilva, Glenda Nicioli da-
dc.contributor.authorRocha, Noeme Sousa-
dc.date.accessioned2016-07-07T12:34:30Z-
dc.date.accessioned2016-10-25T21:44:02Z-
dc.date.available2016-07-07T12:34:30Z-
dc.date.available2016-10-25T21:44:02Z-
dc.date.issued2013-
dc.identifierhttp://dx.doi.org/10.4236/ojpathology.2013.34027-
dc.identifier.citationOpen Journal of Pathology, v. 3, n. 4, p. 144-149, 2013.-
dc.identifier.issn2164-6783-
dc.identifier.urihttp://hdl.handle.net/11449/140573-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/140573-
dc.description.abstractBackground: Experimental studies have shown that cyclo-oxygenase-2 (Cox2) is related to the development and progression of tumors, since this enzyme is induced and expressed by cells such as macrophages, osteoblasts, “activated” endothelial cells, and tumor cells. The activity in tumors includes proliferation, cell transformation, tumor growth, invasion and metastasis and may play an important role in carcinogenesis of the canine osteosarcoma, since it has high expression in tissue fragments. The combination of selective Cox2 inhibitors and other treatment modalities is the basis for a new anti-cancer therapy strategy. This in vitro study exposed primary cells of five different canine osteosarcoma cultures to selective Cox2 inhibitor at increasing concentrations and times. Results: For Cox2 negative cultures, despite the absence of differences, greater sensitivity of cells to treatment was observed. For Cox2 positive cultures, a higher number of necrotic cells were observed (P ≤ 0.05), when compared with negative cultures. For exposure times with Celecoxib doses, no difference (P > 0.05) was found between the three times analyzed for living, apoptotic and apoptotic/necrotic cells. There are similarities in the values of 24 h and 48 h, with slight reduction of living cells, increasing those undergoing apoptosis and apoptosis/necrosis. There was significance for necrosis (P ≤ 0.05). In 72 hours, a significant difference was observed between the other two previous values (P ≤ 0.05). It was found for the group of 100 µM·L−1 , that there was a numerically greater signaling for apoptosis and lower (P = 0.08) for necrosis, and this point was the onset of the pharmacodynamic phenomenon, with drop in the values for living cells and increased number of necrotic cells, with a tendency (P = 0.08) for reducing the percentage of necrotic cells for the group of 100 µM·L−1 when compared to that of 10 µM·L−1 . Conclusions: For Cox2 positive and negative cultures, there was difference for necrotic cells and there was no difference between Cox2 positive and Cox2 negative groups in relation to the percentage of living cells and apoptotic and apoptotic/necrotic cells. At time of 72 hours, higher percentage of living cells, lower percentage of apoptotic cells and increased percentage of necrotic cells in relation to groups of 24 and 48 hours were observed. A tendency for reducing the percentage of necrotic cells for the group of 100 µM·L−1 when compared to that of the group of 10 µM·L−1 was observed.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.format.extent144-149-
dc.language.isoeng-
dc.sourceCurrículo Lattes-
dc.subjectCanineen
dc.subjectOsteosarcomaen
dc.subjectCyclo-oxygenase-2en
dc.subjectCelecoxiben
dc.titleRole of selective cyclo-oxygenase-2 inhibitor celecoxib in canine osteosarcoma cell cultureen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversity of Porto-
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)-
dc.description.affiliationUniversity of Porto, Institute of Molecular Pathology and Immunology-
dc.description.affiliationUnespUniversidade Estadual Paulista, Departamento de Clínica Veterinária, Faculdade de Medicina Veterinária e Zootecnia de Botucatu-
dc.description.affiliationUnespUniversidade Estadual Paulista, Departamento de Patologia, Faculdade de Medicina de Botucatu-
dc.description.affiliationUnespUniversidade Estadual Paulista, Departamento de Reprodução Animal e Radiologia Veterinária, Faculdade de Medicina Veterinária e Zootecnia de Botucatu-
dc.description.sponsorshipIdFAPESP: 2009/53493-9-
dc.description.sponsorshipIdFAPESP: 2009/53777-7-
dc.identifier.doi10.4236/ojpathology.2013.34027-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofOpen Journal of Pathology-
dc.identifier.lattes9921033869437460-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.